Showing results (111-120 of 351) with videos related to
Sort By:
Pageof 36
Journal of Medical Virology|June 14, 2008
Substitution of amino acid 70 in the hepatitis C virus core region of genotype 1b is an important predictor of elevated alpha-fetoprotein in patients without hepatocellular carcinomaNorio Akuta, Fumitaka Suzuki, Yusuke Kawamura, et al.Hepatology Research : the Official Journal of the Japan Society of Hepatology|October 18, 2003
Usefulness of serum KL-6 for early diagnosis of idiopathic pulmonary fibrosis in patients with hepatitis C virusYasuji Arase, Kenji Ikeda, Akihito Tsubota, et al.Cancer|January 2, 2009
High serum des-gamma-carboxy prothrombin level predicts poor prognosis after radiofrequency ablation of hepatocellular carcinomaMasahiro Kobayashi, Kenji Ikeda, Yusuke Kawamura, et al.Journal of Gastroenterology|October 8, 2005
Determinants of serum ALT normalization after phlebotomy in patients with chronic hepatitis C infectionYusuke Kawamura, Norio Akuta, Hitomi Sezaki, et al.The American Journal of Medicine|April 21, 2009
Necessities of interferon therapy in elderly patients with chronic hepatitis CKenji Ikeda, Yasuji Arase, Yusuke Kawamura, et al.Journal of Medical Virology|July 4, 2007
Comparison of interferon and lamivudine treatment in Japanese patients with HBeAg positive chronic hepatitis BYasuji Arase, Kenji Ikeda, Fumitaka Suzuki, et al.Hepatology Research : the Official Journal of the Japan Society of Hepatology|September 3, 2011
Highly sensitive AFP-L3% assay is useful for predicting recurrence of hepatocellular carcinoma after curative treatment pre- and postoperativelyMasahiro Kobayashi, Tetsuya Hosaka, Kenji Ikeda, et al.BMC Gastroenterology|October 27, 2017
Portal vein thrombosis in liver cirrhosis: incidence, management, and outcomeShunichiro Fujiyama, Satoshi Saitoh, Yusuke Kawamura, et al.Oncology|October 23, 2022
Simple Predictive Markers and Clinicopathological Features of Primary Liver Cancer following HCV Clearance with Direct-Acting AntiviralsNorio Akuta, Hitomi Sezaki, Shunichiro Fujiyama, et al.Oncology|June 14, 2014
Prevention of disease progression with anti-inflammatory therapy in patients with HCV-related cirrhosis: a Markov modelKenji Ikeda, Yusuke Kawamura, Masahiro Kobayashi, et al.Pageof 36